MTHRY vs ACA
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
MTHRY · M3 (ADR)$5.69 ▼ 3.40%
ACA · Arcosa$149.15 ▲ 0.00%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- MTHRY -10.3%
- ACA +49.3%
Head to head
| Metric | MTHRY | ACA |
|---|---|---|
| Price | $5.69 | $149.15 |
| Change today | ▼ 3.40% | ▲ 0.00% |
| Market cap | $7.33B | $7.32B |
| Return, 3 months | +12.7% | +2.9% |
| Return, year to date | -14.6% | +40.5% |
| Return, 1 year | -16.7% | +60.5% |
| P/E (TTM) | 25.9 | 15.0 |
| P/B | 2.9 | 2.5 |
| P/E percentile vs own 5y | – | 24th |
| Dividend yield | 1.21% | 0.13% |
| Revenue growth (YoY, latest qtr) | – | +1.7% |
| Net profit growth (YoY) | – | +450.3% |
| Gross margin | – | 22.8% |
| Operating margin | – | 12.0% |
| Net margin | – | 16.8% |
| Return on equity | – | 17.9% |
| Analyst target vs. price | – | +0.6% |
| Analyst buy share | – | 0% |
| RSI (14) | 48 | 83 |
| 30-day volatility | 49.6% | 3.9% |
| Max drawdown, 1 year | -53.5% | -21.4% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | – | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- MTHRY is the largest of the group by market value.
- ACA has returned the most over the past year.
- ACA carries the lowest trailing P/E.
- MTHRY pays the highest dividend yield.
- ACA has been the calmest stock over the last 30 days.